In colorectal cancer, Ube2v1 inhibits Sirt1, reduces H4K16 acetylation, suppresses autophagy, and promotes EMT and invasion, indicating unfavorable prognosis [73]. This evidence concerns the gene SIRT1 and colorectal cancer.